Bryan Tysinger

1.1k total citations
37 papers, 557 citations indexed

About

Bryan Tysinger is a scholar working on General Health Professions, Health and Economics and Econometrics. According to data from OpenAlex, Bryan Tysinger has authored 37 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in General Health Professions, 14 papers in Health and 10 papers in Economics and Econometrics. Recurrent topics in Bryan Tysinger's work include Health disparities and outcomes (14 papers), Global Health Care Issues (13 papers) and demographic modeling and climate adaptation (9 papers). Bryan Tysinger is often cited by papers focused on Health disparities and outcomes (14 papers), Global Health Care Issues (13 papers) and demographic modeling and climate adaptation (9 papers). Bryan Tysinger collaborates with scholars based in United States, Singapore and Italy. Bryan Tysinger's co-authors include Dana P. Goldman, Julie Zissimopoulos, Eileen M. Crimmins, Yi Chen, Patricia A. St. Clair, Étienne Gaudette, Rebeca Wong, Hanke Heun‐Johnson, Darius Lakdawalla and Mark A. Hlatky and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Bryan Tysinger

32 papers receiving 548 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bryan Tysinger United States 14 188 148 135 78 73 37 557
Kim Moesgaard Iburg Denmark 16 275 1.5× 178 1.2× 192 1.4× 72 0.9× 106 1.5× 31 854
Shu‐Chuan Jennifer Yeh Taiwan 13 190 1.0× 110 0.7× 211 1.6× 35 0.4× 54 0.7× 35 721
Alejandra Michaels-Obregón United States 10 136 0.7× 128 0.9× 245 1.8× 30 0.4× 61 0.8× 14 585
Jocelyn Charles Canada 13 210 1.1× 193 1.3× 65 0.5× 43 0.6× 91 1.2× 36 588
Song Hee Hong United States 15 160 0.9× 96 0.6× 62 0.5× 141 1.8× 34 0.5× 46 583
Monica Cepoiu‐Martin Canada 11 295 1.6× 224 1.5× 64 0.5× 44 0.6× 77 1.1× 19 718
Mahtab Alizadeh-Khoei Iran 14 107 0.6× 76 0.5× 98 0.7× 25 0.3× 82 1.1× 46 621
Maja Barker Ireland 7 131 0.7× 44 0.3× 135 1.0× 78 1.0× 67 0.9× 8 485
Wei Duan‐Porter United States 15 187 1.0× 71 0.5× 83 0.6× 65 0.8× 66 0.9× 33 815
Alison Luciano United States 14 233 1.2× 171 1.2× 44 0.3× 71 0.9× 44 0.6× 28 661

Countries citing papers authored by Bryan Tysinger

Since Specialization
Citations

This map shows the geographic impact of Bryan Tysinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan Tysinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan Tysinger more than expected).

Fields of papers citing papers by Bryan Tysinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan Tysinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan Tysinger. The network helps show where Bryan Tysinger may publish in the future.

Co-authorship network of co-authors of Bryan Tysinger

This figure shows the co-authorship network connecting the top 25 collaborators of Bryan Tysinger. A scholar is included among the top collaborators of Bryan Tysinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryan Tysinger. Bryan Tysinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tysinger, Bryan, et al.. (2025). Long‐term value of lecanemab to individuals and families. Alzheimer s & Dementia Translational Research & Clinical Interventions. 11(3). e70151–e70151.
2.
Zissimopoulos, Julie, et al.. (2025). Real-World Evidence of Brexpiprazole Use and 6-Month Mortality, Hospitalization, and Emergency Department Visits Among Persons With Dementia. Neurology. 105(3). e213717–e213717. 1 indexed citations
3.
Tysinger, Bryan, Hwee Lin Wee, Mythily Subramaniam, et al.. (2025). Disease burden, lifetime healthcare cost and long-term intervention impact projections among older adults in Singapore. Nature Aging. 5(7). 1358–1369.
4.
Heun‐Johnson, Hanke, Johanna Thunell, Jonathan N. Cloughesy, et al.. (2025). Lifetime burden of prescription medication for insomnia in middle-aged and older adults in the US: a microsimulation study. The Lancet Regional Health - Americas. 52. 101284–101284. 1 indexed citations
5.
Gračner, Tadeja, Ritika Chaturvedi, Hanke Heun‐Johnson, et al.. (2025). The burden of cognitive impairment. Alzheimer s & Dementia. 21(8). e70436–e70436.
6.
Currid‐Halkett, Elizabeth, et al.. (2024). The urban–rural gap in older Americans’ healthy life expectancy. The Journal of Rural Health. 41(1). e12875–e12875. 2 indexed citations
7.
May, Peter, Charles Normand, Samantha Smith, et al.. (2024). How many people will live and die with serious illness in Ireland to 2040? Estimated needs and costs using microsimulation. The Journal of the Economics of Ageing. 29. 100528–100528.
8.
Tysinger, Bryan, et al.. (2023). The Forgotten Middle: Worsening Health And Economic Trends Extend To Americans With Modest Resources Nearing Retirement. Health Affairs. 42(9). 1230–1240. 3 indexed citations
9.
Heun‐Johnson, Hanke, et al.. (2022). Using dynamic microsimulation to project cognitive function in the elderly population. PLoS ONE. 17(9). e0274417–e0274417. 1 indexed citations
10.
Hlávka, Jakub, et al.. (2022). Access to Disease-Modifying Alzheimer’s Therapies: Addressing Possible Challenges Using Innovative Payment Models. Value in Health. 25(11). 1828–1836. 1 indexed citations
11.
Tysinger, Bryan, et al.. (2022). The Returns to Preventing Chronic Disease in Europe and the United States. Journal of Human Capital. 16(1). 157–182. 1 indexed citations
12.
Joyce, Geoffrey, et al.. (2022). Benzodiazepine use and the risk of dementia. Alzheimer s & Dementia Translational Research & Clinical Interventions. 8(1). e12309–e12309. 15 indexed citations
13.
Gong, Cynthia L., et al.. (2020). Lifetime Burden of Adult Congenital Heart Disease in the USA Using a Microsimulation Model. Pediatric Cardiology. 41(7). 1515–1525. 10 indexed citations
14.
Chen, Christopher, Jue Tao Lim, Lijia Wang, et al.. (2019). The long-term impact of functional disability on hospitalization spending in Singapore. The Journal of the Economics of Ageing. 14. 100193–100193. 33 indexed citations
15.
Kim, Dae Jung, Cynthia Chen, Bryan Tysinger, et al.. (2019). Smoking, life expectancy, and chronic disease in South Korea, Singapore, and the United States: A microsimulation model. Health Economics. 30(S1). 92–104. 13 indexed citations
16.
Tysinger, Bryan, et al.. (2018). Innovation in Heart Failure Treatment. JACC Heart Failure. 6(5). 401–409. 42 indexed citations
17.
González‐González, César, Bryan Tysinger, Dana P. Goldman, & Rebeca Wong. (2017). Projecting diabetes prevalence among Mexicans aged 50 years and older: the Future Elderly Model-Mexico (FEM-Mexico). BMJ Open. 7(10). e017330–e017330. 26 indexed citations
18.
Clair, Patricia St., et al.. (2017). Using Self-reports or Claims to Assess Disease Prevalence. Medical Care. 55(8). 782–788. 31 indexed citations
19.
Auerbach, Alan J., Kerwin Charles, Courtney Coile, et al.. (2017). How the Growing Gap in Life Expectancy May Affect Retirement Benefits and Reforms. The Geneva Papers on Risk and Insurance Issues and Practice. 42(3). 475–499. 34 indexed citations
20.
Gaudette, Étienne, et al.. (2015). Health and Health Care of Medicare Beneficiaries in 2030. Forum for Health Economics & Policy. 18(2). 75–96. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kim Moesgaard Iburg Breakdown of academic impact, for papers by Shu‐Chuan Jennifer Yeh Breakdown of academic impact, for papers by Alejandra Michaels-Obregón Breakdown of academic impact, for papers by Jocelyn Charles Breakdown of academic impact, for papers by Song Hee Hong Breakdown of academic impact, for papers by Monica Cepoiu‐Martin Breakdown of academic impact, for papers by Mahtab Alizadeh-Khoei Breakdown of academic impact, for papers by Maja Barker Breakdown of academic impact, for papers by Wei Duan‐Porter Breakdown of academic impact, for papers by Alison Luciano
Rankless by CCL
2026